Agile Therapeutics, Inc. (NASDAQ:AGRX) Basic Net EPS Stands At $-1.38

0

Agile Therapeutics, Inc. (NASDAQ:AGRX) had an annual basic consolidated EPS of $-1.3778 for the period ended 2015-12-31. For the quarter ended 2015-12-31 which was on quarterly basis, the basic consolidated EPS reading was $-1.3778.

EPS from continuing operations

Agile Therapeutics, Inc. (NASDAQ:AGRX) reported $-1.3778 as the basic EPS from continuing operations for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations stood at $-1.3778 for the three-month period ended 2015-12-31.

EPS contribution from parent

From its parent company, Agile Therapeutics, Inc. (NASDAQ:AGRX) received basic EPS of $-1.3778 for the annual period ended 2015-12-31. EPS contribution from the parent company was $-1.3778 which was on quarterly basis for the period ended 2015-12-31.

Basic net EPS

A basic net EPS of $-1.38 was reported by Agile Therapeutics, Inc. (NASDAQ:AGRX) for the annual period ended 2015-12-31. For the three-month period ended 2015-12-31 which was on a quarterly basis, the company’s basic net EPS stood at $-1.38.

Consolidated diluted EPS

For the period ended 2015-12-31, $-1.3778 was reported as the annual consolidated diluted EPS reading. Consolidated diluted EPS was $-1.3778 for the quarter ended 2015-12-31.

Basic diluted EPS

Diluted EPS reading from continuing operation was $-1.3778 which was on annual basis but for the period ended 2015-12-31. From continuing operations, Diluted EPS was $-1.3778 for the quarter ended 2015-12-31.

Net diluted EPS

Net diluted EPS reading was $-1.38 for the annual period ended 2015-12-31 while the net diluted EPS for the quarterly period ended 2015-12-31 stood at $-1.38.

Diluted EPS from parent

Diluted EPS of $-1.3778 was received by Agile Therapeutics, Inc. (NASDAQ:AGRX) from its parent company which was for the annual period ended 2015-12-31. For the quarter ended 2015-12-31, diluted EPS contribution from the parent was $-1.3778 on quarterly basis. For the annual period ended 2015-12-31, $-1.38 was posted by Agile Therapeutics, Inc. (NASDAQ:AGRX) as net basic EPS reading.

For the quarter ended 2015-12-31, basic net EPS of $-1.38 was reported. The period ended 2015-12-31 had annual average basic shares outstanding of 22.017. But it was 22.017 for the quarter ended 2015-12-31. 22.017 and 22.017 were the diluted shares outstanding for the fiscal year ended is 2015-12-31 respectively.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 20 times, 1 visits today)